Developments in US Antitrust Litigation—2020 Year in Review
Arnold Porter
JUNE 2, 2021
The direct purchasers' suit, filed in 2012, alleged that GSK and Teva violated the antitrust laws through their settlement agreement to end a patent dispute over GSK's anti-epilepsy drug Lamictal and Teva's generic equivalent, lamotrigine.[[N:Complaint, 17, 2012).]] and its subsidiary, AbbVie Biotechnology, Ltd.
98 
Let's personalize your content